Literature DB >> 15693890

Vascular endothelial growth factor (VEGF-C1)-dependent inflammatory response of podocytes in nephrotic syndrome glomerulopathies in children: an immunohistochemical approach.

D Ostalska-Nowicka1, J Zachwieja, M Nowicki, E Kaczmarek, A Siwinska, M Witt.   

Abstract

AIMS: To analyse expression and distribution of vascular endothelial growth factor (VEGF-C1), podocalyxin and synaptopodin within renal tissue in nephrotic syndrome glomerulopathies in children. METHODS AND
RESULTS: Renal biopsies performed at the time and in the manner recommended by the World Health Organization. The study group consisted of submicroscopic glomerulonephritis (n = 10), diffuse mesangial proliferation (n = 14) and focal segmental glomerulosclerosis (n = 5). The control tissue consisted of macroscopically normal appearing cortex taken from kidneys resected for localized neoplasms (n = 3). Material for immunohistochemistry was fixed in Bouin's solution and embedded in paraffin. Indirect immunohistochemistry using monoclonal anti-human antibodies directed against VEGF-C1, podocalyxin and synaptopodin was employed. The distribution of markers was quantified by computerized image analysis. In non-sclerosed glomeruli (within podocyte cytoplasm), VEGF-C1 was more expressed in podocytes of all groups (P < 0.0002), while the distribution of synaptopodin was less expressed in all groups (P < 0.0002). There was no statistical difference between all groups in the expression of podocalyxin.
CONCLUSIONS: The increased permeability of the filtration barrier in steroid-resistant glomerulopathies may be a consequence of subcellular changes in podocytes resulting from decreased expression of synaptopodin. Moreover, impaired permeability of endothelium could be secondary to increased expression of podocyte-derived VEGF-C1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15693890     DOI: 10.1111/j.1365-2559.2005.02076.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  4 in total

1.  Is mesangial hypercellularity with glomerular immaturity a variant of glomerulosclerosis?

Authors:  Danuta Ostalska-Nowicka; Jacek Zachwieja; Michal Nowicki; Elzbieta Kaczmarek; Martin Witt
Journal:  Pediatr Nephrol       Date:  2007-01-19       Impact factor: 3.714

2.  Emerging translational bioinformatics: knowledge-guided biomarker identification for cancer diagnostics.

Authors:  John H Phan; Qiqin Yin-Goen; Andrew N Young; May D Wang
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009

3.  Ezrin--a useful factor in the prognosis of nephrotic syndrome in children: an immunohistochemical approach.

Authors:  D Ostalska-Nowicka; J Zachwieja; M Nowicki; E Kaczmarek; A Siwinska; M Witt
Journal:  J Clin Pathol       Date:  2006-03-07       Impact factor: 3.411

4.  Skeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome.

Authors:  V Phan; T Blydt-Hansen; J Feber; N Alos; S Arora; S Atkinson; L Bell; C Clarson; R Couch; E A Cummings; G Filler; R M Grant; J Grimmer; D Hebert; B Lentle; J Ma; M Matzinger; J Midgley; M Pinsk; C Rodd; N Shenouda; R Stein; D Stephure; S Taback; K Williams; F Rauch; K Siminoski; L M Ward
Journal:  Osteoporos Int       Date:  2013-08-16       Impact factor: 4.507

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.